August 2019 Back to School

Asthma Watch: Trelegy Ellipta Hits Phase 3 Asthma Marks, Eyes New Indication

August 22, 2019

Features

Pivotal phase 3 trial results show benefits for once-daily fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI; Trelegy Ellipta) in patients with uncontrolled asthma compared with standard FF/VI (Breo Ellipta) therapy.

Rocklatan From Aerie Pharmaceuticals, Inc

August 15, 2019

Rx Focus

The FDA has approved Rocklatan (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005%, from Aerie Pharmaceuticals, Inc, for the reduction of elevated intraocular pressure (IOP) in patients with ocular hypertension or open-angle glaucoma.

Mold Can Cause a Persistent Cough

August 14, 2019

Patient Education

Cladosporium, Penicillium, Alternaria, and Aspergillus are the most common molds found in almost all environments.1 These are just a few of the hundreds of thousands of species of fungi.

Stay on Top of Vaccine Recommendations to Counsel Patients

August 07, 2019

From the Chairman

https://pharmacytimes.com/peer-exchange/the-progression-of-immunization-At its meeting in June, the ACIP made some very interesting suggestions, noting that all children and adolescents between ages 2 and 18 who have not previously received the hepatitis A vaccine should receive a catch-up vaccination and encouraging a change in the human papillomavirus vaccination guidelines to cover men up to age 26.